In pancreatic cancer (PC), ALKBH5 enhances the stability of PER1 by removing the m6A modification on PER1 mRNA, thereby activating the ATM-CHK2-P53/CDC25C signaling pathway to inhibit tumor cell growth54. Here, ALKBH5 is linked to familial pancreatic carcinoma.